Related Experiment Video
Updated: Aug 22, 2026
Identification of Rare Antigen-Specific T Cells from Mouse Lungs with Peptide:Major Histocompatibility Complex Tetramers
Published on: July 19, 2024
Characterization of mouse MAGE-derived H-2Kb-restricted CTL epitopes
Andreas O Eggert1, Mads H Andersen, Heike Voigt
1Department of Dermatology, Julius Maximilians-University Würzburg, Würzburg, Germany. eggert_a@klinik.uni-wuerzburg.de
Abstract:
Immunogenic peptide epitopes from tumor-associated antigens serve as targets for cellular immune responses in numerous clinical trials for therapeutic vaccinations. From these it became evident that prevailing questions can only be addressed in animal models. Hence, problems arise from the fact that while for human melanoma many different immunogenic peptide epitopes are known, for mouse melanoma the available selection is very restricted. To overcome this limitation, we applied reverse immunology to identify Kb-restricted epitopes derived of mouse MAGE. Two epitopes which bind strongly to Kb were selected to test for their immunogenicity in vivo. Spleen cells from mice vaccinated by intradermal injection of mature dendritic cells pulsed with these peptides displayed reactivity to the respective epitopes as measured by enzyme-linked immunospot assays and tetramer staining. The processing and presentation of these epitopes was evident by the killing of melanoma cells by the vaccination-induced T cells. Moreover, intravenous challenge with syngeneic melanoma cells demonstrated the protective immunity induced by this vaccination. In summary, we demonstrate the immunogenicity of two Kb-restricted peptide epitopes derived from mouse MAGE proteins which may serve as valuable tool for preclinical evaluation of vaccination strategies.
Insights
Researchers identified two novel mouse MAGE peptide epitopes that are immunogenic and effective in preclinical melanoma models. These findings offer valuable tools for evaluating therapeutic cancer vaccination strategies in animal studies.
Area of Science:
- Immunology
- Oncology
- Vaccinology
Background:
- Therapeutic cancer vaccines target tumor-associated antigens using immunogenic peptide epitopes.
- Existing research has numerous known human melanoma epitopes but a limited selection for mouse models.
- Animal models are crucial for addressing questions in therapeutic vaccination research.
Purpose of the Study:
- To identify and characterize novel Kb-restricted peptide epitopes from mouse MAGE proteins using reverse immunology.
- To evaluate the immunogenicity and efficacy of these identified epitopes in a preclinical mouse melanoma model.
Main Methods:
- Applied reverse immunology to identify Kb-restricted epitopes from mouse MAGE proteins.
- Selected two high-affinity binding epitopes for in vivo immunogenicity testing.
- Assessed cellular immune responses using enzyme-linked immunospot assays and tetramer staining.
- Evaluated anti-tumor immunity through melanoma cell killing assays and syngeneic tumor challenge.
Main Results:
- Identified two Kb-restricted peptide epitopes derived from mouse MAGE proteins.
- Demonstrated significant spleen cell reactivity to the selected epitopes post-vaccination.
- Confirmed processing and presentation of epitopes by vaccination-induced T cells, leading to melanoma cell killing.
- Showcased protective immunity against syngeneic melanoma cell challenge.
Conclusions:
- The study successfully identified two immunogenic Kb-restricted peptide epitopes from mouse MAGE.
- These epitopes are effective in inducing cellular immune responses and protective immunity in a preclinical melanoma model.
- The identified epitopes serve as valuable tools for the preclinical evaluation of cancer vaccination strategies.
